Over the past decades, focusing on a battery of conventional genes/proteins involved in the neurodegeneration has been disappointing in the field of neurodegenerative therapeutics. With the scientific responsibility and integrity, Neuracle Science is a clinical stage biotech company specialized in the development of breakthrough therapies for those who are living with serious and devastating neurodegenerative diseases. We provide a foundation for disease-modifying treatments for neurodegenerative diseases, discovering a completely novel and invaluable gene/protein target with unknown significance using non-biased study.
Neuracle Science is based in Seoul, South Korea. We were founded in 2015 by scientific leaders in neuroscience, bioinformatics-based drug discovery, GPCR-mediated signaling, and antibody drug.
Company Details
- Employees
- 15
- Founded
- -
- Address
- Research And Business Building 406, Science Campus, Korea University, 145, Anam-Ro, Seongbuk-Gu, Seoul,02841,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.neuracles.com
- HQ
- Seoul
Neuracle Science Questions
Neuracle Science's website is http://www.neuracles.com
Neuracle Science's LinkedIn profile is https://kr.linkedin.com/company/neuraclescience
Neuracle Science has
15 employees.
View email and phone details for 15
employees at Neuracle Science.
Neuracle Science's industry is
Biotechnology Research
Neuracle Science's top competitors are
Wearable Sensing,
Brain Products Gmbh,
Audiocure Pharma Gmbh,
Neuracle Technologies,
博睿康科技(常州)股份有限公司,
Nirx Medical Technologies,
Neuracle Neuroscience,
Synchron,
Rznomics Inc.,
Blackrock Neurotech.
Neuracle Science's categories are Biotechnology Research
Neuracle Science's founding year is 2015
